###begin article-title 0
###xml 64 68 <span type="species:ncbi:10090">Mice</span>
Loss of Sugar Detection by GLUT2 Affects Glucose Homeostasis in Mice
###end article-title 0
###begin p 1
Conceived and designed the experiments: AL ML. Performed the experiments: ES ML PE AH PS EB. Analyzed the data: AL ES ML PE PS EB. Contributed reagents/materials/analysis tools: PE. Wrote the paper: AL ES ML.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 258 265 258 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Mammals must sense the amount of sugar available to them and respond appropriately. For many years attention has focused on intracellular glucose sensing derived from glucose metabolism. Here, we studied the detection of extracellular glucose concentrations in vivo by invalidating the transduction pathway downstream from the transporter-detector GLUT2 and measured the physiological impact of this pathway.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 124 132 124 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 12 16 <span type="species:ncbi:10090">mice</span>
###xml 238 253 <span type="species:ncbi:10090">transgenic mice</span>
###xml 387 402 <span type="species:ncbi:10090">Transgenic mice</span>
We produced mice that ubiquitously express the largest cytoplasmic loop of GLUT2, blocking glucose-mediated gene expression in vitro without affecting glucose metabolism. Impairment of GLUT2-mediated sugar detection transiently protected transgenic mice against starvation and streptozotocin-induced diabetes, suggesting that both low- and high-glucose concentrations were not detected. Transgenic mice favored lipid oxidation, and oral glucose was slowly cleared from blood due to low insulin production, despite massive urinary glucose excretion. Kidney adaptation was characterized by a lower rate of glucose reabsorption, whereas pancreatic adaptation was associated with a larger number of small islets.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
###xml 54 69 <span type="species:ncbi:10090">transgenic mice</span>
Molecular invalidation of sugar sensing in GLUT2-loop transgenic mice changed multiple aspects of glucose homeostasis, highlighting by a top-down approach, the role of membrane glucose receptors as potential therapeutic targets.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 605 608 604 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Matschinsky1">[1]</xref>
###xml 609 612 608 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Schuit1">[3]</xref>
###xml 700 703 699 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Girard1">[4]</xref>
###xml 705 708 704 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Vaulont1">[5]</xref>
###xml 710 713 709 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Towle1">[6]</xref>
###xml 882 889 881 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Sensing of sugar is a survival mechanism enabling organisms to know when to constitute and mobilize tissue energy stores. It is known that glucose homeostasis relies on appropriate detection of glucose concentration, but glucose-sensing mechanisms remain poorly understood in mammalian cells. Intracellular glucose is sensed and the resulting signal relayed by metabolic messengers in tissues. Glucokinase and mitochondrial oxidative fluxes (ATP/ADP ratio) are involved in regulation of ATP-sensitive K+ channels controlling insulin secretion and are well-described glucose sensors in pancreatic ss cells [1]-[3]. Intracellular glucose metabolism stimulates sensitive-gene transcription in the liver [4], [5], [6]. Intracellular glucose metabolism is a common feature of mammalian cells and modulation of glucose sensing by metabolic inhibitors, although potent, is not recommended in vivo as most cell functions and vital parameters would be affected.
###end p 9
###begin p 10
###xml 96 99 96 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Ozcan1">[7]</xref>
###xml 204 207 204 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Holsbeeks1">[8]</xref>
###xml 387 390 387 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Bandyopadhyay1">[9]</xref>
###xml 662 666 662 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Guillam1">[10]</xref>
###xml 773 777 773 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Santer1">[11]</xref>
###xml 0 6 <span type="species:ncbi:4932">Yeasts</span>
###xml 598 602 <span type="species:ncbi:10090">mice</span>
###xml 697 705 <span type="species:ncbi:9606">patients</span>
###xml 896 901 <span type="species:ncbi:9606">human</span>
###xml 910 914 <span type="species:ncbi:10090">mice</span>
###xml 1008 1012 <span type="species:ncbi:10090">mice</span>
###xml 1017 1020 <span type="species:ncbi:9606">man</span>
Yeasts detect extracellular sugar concentrations with proteins located in the external membrane [7], including sugar receptors of the GPCR family and transporter-detectors of the sugar transporter family [8]. In adipocytes, the glucose transporter GLUT1 detects glucose with its C-terminus domain activating the ERK pathway by a mechanism independent of glucose transport and metabolism [9]. In pancreatic beta cells, investigations have yield conflicting results concerning the possible role of detector for GLUT2 in glucose-induced insulin secretion. The group of B. Thorens demonstrated that in mice GLUT2 participates to the first phase of insulin secretion [10]. Unexpectedly, Fanconi-Bickel patients bearing GLUT2 invalidating mutations do not develop overt diabetes [11] but their insulin secretions were not investigated. This suggests that GLUT2 is less involved in insulin secretion in human than in mice. Importantly, the role of GLUT2 in insulin synthesis has not been fully characterized yet in mice and man.
###end p 10
###begin p 11
###xml 185 189 185 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Guillemain1">[12]</xref>
###xml 350 354 350 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-DiezSampedro1">[13]</xref>
###xml 538 545 538 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
In hepatic cells, GLUT2 detects glucose and activates a signaling pathway through its large cytoplasmic loop leading to glucose-induced transcription, independent of glucose metabolism [12]. The sodium-glucose transporter homolog SGLT-3, was identified as a glucose sensor in the plasma membrane of enteric neurons triggering membrane depolarization [13]. Due to these plasma membrane detectors, cells can adapt to changes in extracellular sugar concentrations. The role of glucose detectors in glucose homeostasis has not been evaluated in vivo. Such a study should provide information on the importance of the glucose-sensing pathway triggered by detectors, and help elucidate the role of plasma membrane therapeutic targets in modulation of glucose homeostasis.
###end p 11
###begin p 12
###xml 403 411 403 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 411 415 411 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Guillemain1">[12]</xref>
###xml 535 539 535 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Bady1">[14]</xref>
###xml 541 545 541 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Guillam2">[15]</xref>
###xml 547 551 547 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Marty1">[16]</xref>
###xml 530 534 <span type="species:ncbi:10090">mice</span>
###xml 676 680 <span type="species:ncbi:10090">mice</span>
GLUT2 is expressed in various tissues involved in glucose homeostasis; thus, we investigated the physiological significance of GLUT2 detection of extracellular glucose concentration. GLUT2 is involved in metabolic glucose sensing by mediating bi-directional glucose transport, adjusting intracellular glucose concentration. It is also involved in the detection of sugar abundance at the plasma membrane in vitro[12]. GLUT2 has been shown to contribute to control of food intake and secretion of insulin and glucagon in GLUT2-null mice [14], [15], [16], but detection of both intracellular and extracellular glucose concentrations as well as transport are invalidated in those mice.
###end p 12
###begin p 13
###xml 15 22 15 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 221 229 221 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 264 268 264 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Guillemain1">[12]</xref>
###xml 283 298 <span type="species:ncbi:10090">transgenic mice</span>
We quantified, in vivo, the physiological contribution of extracellular sugar detection independent of changes in glucose metabolism. For this purpose, we used a molecular tool that blocks glucose-induced gene expression in vitro, but preserves glucose metabolism [12]. We generated transgenic mice expressing the GLUT2-loop domain to prevent the detection of extracellular sugar abundance. We report here the impact of the loss of extracellular glucose detection on various aspects of glucose homeostasis.
###end p 13
###begin title 14
Results
###end title 14
###begin title 15
###xml 25 40 <span type="species:ncbi:10090">transgenic mice</span>
Generation of GLUT2-loop transgenic mice
###end title 15
###begin p 16
###xml 117 124 117 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 199 206 199 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001288-g001">Fig. 1A</xref>
###xml 13 28 <span type="species:ncbi:10090">transgenic mice</span>
###xml 143 158 <span type="species:ncbi:10090">transgenic mice</span>
###xml 209 214 <span type="species:ncbi:10090">Mouse</span>
###xml 513 517 <span type="species:ncbi:10090">mice</span>
We generated transgenic mice expressing the large cytoplasmic GLUT2 loop to investigate its sugar detection function in vivo. We obtained four transgenic mice with various copy numbers of transgene (Fig. 1A). Mouse 'W' had the highest copy number of transgene, growth failure and urinary glucose loss, but survived at weaning and did not develop diabetes. Unfortunately, 'W' was sterile. Founder 'B' had a high transgene copy number and was viable but some homozygous did not survive. Heterozygous and homozygous mice from 'P' and 'G' founders were viable.
###end p 16
###begin title 17
###xml 25 40 <span type="species:ncbi:10090">transgenic mice</span>
Generation of GLUT2-loop transgenic mice.
###end title 17
###begin p 18
###xml 88 92 <span type="species:ncbi:10090">mice</span>
###xml 348 363 <span type="species:ncbi:10090">transgenic mice</span>
A: Quantification of the transgene copy number in genomic DNA from independent lines of mice (Tg G, P, B and W) to the reference gene Apolipoprotein A1 (ApoA1). B: RT-PCR analysis of transgene and L19 control mRNA levels in various tissues. C: Immunoprecipitation and immunoblot analysis showing the presence of GLUT2 loop in liver homogenate from transgenic mice.
###end p 18
###begin p 19
###xml 130 137 130 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001288-g001">Fig. 1B</xref>
###xml 449 456 449 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001288-g001">Fig. 1C</xref>
###xml 195 199 <span type="species:ncbi:10090">mice</span>
Transgene mRNA was present in all the tissues tested, as expected from the ubiquitous actin promoter used, but at various levels (Fig. 1B). Transgene mRNA expression was absent in wild-type (WT) mice. There was no clear correlation between cDNA copy number and mRNA levels of the transgene. We detected the protein coded by the transgene by immunoprecipitation of liver extracts with a specific antibody raised against the GLUT2 intracellular loop (Fig. 1C).
###end p 19
###begin p 20
###xml 32 47 <span type="species:ncbi:10090">transgenic mice</span>
Thus, we created three lines of transgenic mice expressing various amounts of the transgene in GLUT2- and non GLUT2-expressing tissues.
###end p 20
###begin title 21
Invalidation of extracellular sugar detection in GLUT2 expressing tissues
###end title 21
###begin p 22
###xml 25 33 25 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 145 152 145 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 625 632 625 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001288-g002">Fig. 2A</xref>
###xml 701 708 701 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001288-g002">Fig. 2A</xref>
###xml 745 752 745 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
###xml 206 210 <span type="species:ncbi:10090">mice</span>
###xml 256 260 <span type="species:ncbi:10090">mice</span>
###xml 562 566 <span type="species:ncbi:10090">mice</span>
###xml 684 699 <span type="species:ncbi:10090">transgenic mice</span>
###xml 834 849 <span type="species:ncbi:10090">transgenic mice</span>
###xml 895 899 <span type="species:ncbi:10090">mice</span>
We have previously shown in vitro that the GLUT2 loop blocks glucose stimulation of sensitive gene transcription. In this study, we investigated in vivo the role of the GLUT2 loop. For this purpose, we fed mice with a standard diet, then either fasted the mice for 48h or refed (after fasting) them a glucose-rich diet. We studied genes stimulated directly by glucose and genes stimulated indirectly by insulin secreted in response to glucose ingestion (GLUT2, ChREBP, glucokinase, SREBP-1c). The mRNA coded for these genes accumulated in the liver of wild-type mice 15h after they consumed a glucose-rich diet, as expected (Fig. 2A). However, these mRNAs remained at basal levels in transgenic mice (Fig. 2A), despite similar food consumption. In vivo expression of the GLUT2 loop, therefore, sets the gene-expression profile in fed transgenic mice to the level established in fasted wild-type mice.
###end p 22
###begin title 23
###xml 75 90 <span type="species:ncbi:10090">transgenic mice</span>
Impairment of extracellular sugar detection in GLUT2-expressing tissues in transgenic mice.
###end title 23
###begin p 24
###xml 121 125 <span type="species:ncbi:10090">mice</span>
###xml 310 314 <span type="species:ncbi:10090">mice</span>
###xml 372 376 <span type="species:ncbi:10090">mice</span>
###xml 510 514 <span type="species:ncbi:10090">mice</span>
###xml 636 651 <span type="species:ncbi:10090">transgenic mice</span>
###xml 704 708 <span type="species:ncbi:10090">mice</span>
Effect of a glucose-rich diet on gene expression in liver (A) and adipose tissue (C). Transgenic (Tg) and wild-type (WT) mice were fasted for 48 h and refed for 15 h before liver and epididymal fat pad biopsies. Levels of mRNA were analyzed by real time PCR. Values are presented as means+/-S.E.M. (n = 3 to 5 mice/group). Statistical differences between refed and fasted mice are indicated by *P<0.05, **P<0.01, and ns non significant. B: GLUT2 protein levels in total membrane preparations from the liver of mice fed a glucose-rich diet for five days. D: Blood glucose concentrations during an insulin tolerance test in wild-type and transgenic mice. Values are presented as means+/-S.E.M (n = 8 to 10 mice/group).
###end p 24
###begin p 25
###xml 124 131 124 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001288-g002">Fig. 2B</xref>
###xml 69 84 <span type="species:ncbi:10090">transgenic mice</span>
###xml 157 172 <span type="species:ncbi:10090">transgenic mice</span>
GLUT2 protein levels in liver membrane were similar in wild-type and transgenic mice fed a glucose-rich diet for five days (Fig. 2B). Thus, the phenotype of transgenic mice in which glucose detection by GLUT2 is impaired is not due to low GLUT2 protein levels in liver membranes. This feature is related to liver expression of the transgene inhibiting detection of glucose abundance.
###end p 25
###begin p 26
###xml 272 279 272 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001288-g001">Fig. 1B</xref>
###xml 368 375 368 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001288-g002">Fig. 2C</xref>
###xml 789 796 789 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001288-g002">Fig. 2D</xref>
###xml 456 471 <span type="species:ncbi:10090">transgenic mice</span>
###xml 707 711 <span type="species:ncbi:10090">mice</span>
We assessed the specificity of GLUT2-mediated sugar detection, compared to other GLUTs. For this purpose, we studied tissues that do not express GLUT2 but other members of the GLUT family. We detected transgene mRNA in epididymal adipose tissue (not shown), as in muscle (Fig. 1B). Feeding a glucose-rich diet induced a similar level of accumulation of FAS, SREBP-1c (Fig. 2C) and ACC mRNAs (not shown) in epididymal fat pads from wild-type and GLUT2-loop transgenic mice. These findings show that the expression of the GLUT2 loop did not affect GLUT4-expressing tissues and suggest that other glucose-sensing pathways are involved in these tissues. Moreover, peripheral tissues of transgenic and wild-type mice had similar insulin sensitivity, as determined by an insulin tolerance test (Fig. 2D). These findings indicate that the GLUT2 loop did not interfere with peripheral glucose disposal by muscle and adipose tissues that express GLUT4.
###end p 26
###begin p 27
###xml 18 33 <span type="species:ncbi:10090">transgenic mice</span>
Thus, we produced transgenic mice in which GLUT2-mediated glucose detection was specifically abolished.
###end p 27
###begin title 28
Preference for lipid oxidation
###end title 28
###begin p 29
###xml 162 168 162 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001288-g003">Fig. 3</xref>
###xml 318 331 318 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001288-g003">Fig. 3A and B</xref>
###xml 409 416 409 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001288-g003">Fig. 3C</xref>
###xml 34 38 <span type="species:ncbi:10090">mice</span>
###xml 301 316 <span type="species:ncbi:10090">transgenic mice</span>
###xml 448 463 <span type="species:ncbi:10090">transgenic mice</span>
We investigated the adaptation of mice to impaired detection of glucose abundance by measuring the energy expenditure resulting from glucose and lipid oxidation (Fig. 3). We determined the time course of resting metabolic rate and respiratory quotient averaged at 15-minute intervals in wild-type and transgenic mice (Fig. 3A and B). Resting metabolism, respiratory quotient, and glucose and lipid oxidation (Fig. 3C) were similar in wild-type and transgenic mice before food consumption.
###end p 29
###begin title 30
###xml 22 26 <span type="species:ncbi:10090">mice</span>
Energy expenditure in mice after impairment of extracellular sugar detection.
###end title 30
###begin p 31
###xml 157 161 <span type="species:ncbi:10090">mice</span>
Progression of resting metabolism rate, respiratory quotient and calculated oxidation recorded at ten-second intervals in wild-type (WT) and transgenic (Tg) mice. The test meal was given just before the lights were turned off and the response measured until metabolism rate and respiratory quotient returned to pre-meal levels. The changes in resting metabolism rate and respiratory quotient were included in the calculation of the changes in glucose (Gox) and lipid (Lox) oxidation.
###end p 31
###begin p 32
###xml 528 543 <span type="species:ncbi:10090">transgenic mice</span>
###xml 562 566 <span type="species:ncbi:10090">mice</span>
The peak response for metabolic rate during oral glucose load of 3.6 mg/g (OGTT) occurred after ten minutes and the peak response for respiratory quotient occurred after 30 minutes. There was no significant difference between groups (p = 0.269). Accordingly, there were no differences between groups for glucose and lipid oxidation during oral glucose load. The overall metabolic rate and overall respiratory quotient (measured by the areas under the respective curves) were slightly, but not significantly lower (p = 0.178) in transgenic mice than in wild-type mice during oral glucose load.
###end p 32
###begin p 33
###xml 172 178 172 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001288-g003">Fig. 3</xref>
###xml 748 761 744 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001288-g003">Fig. 3A and B</xref>
###xml 956 963 952 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001288-g003">Fig. 3C</xref>
###xml 13 17 <span type="species:ncbi:10090">mice</span>
###xml 301 316 <span type="species:ncbi:10090">transgenic mice</span>
###xml 444 459 <span type="species:ncbi:10090">transgenic mice</span>
###xml 478 482 <span type="species:ncbi:10090">mice</span>
###xml 583 587 <span type="species:ncbi:10090">mice</span>
###xml 606 610 <span type="species:ncbi:10090">mice</span>
###xml 708 723 <span type="species:ncbi:10090">transgenic mice</span>
###xml 742 746 <span type="species:ncbi:10090">mice</span>
###xml 854 869 <span type="species:ncbi:10090">transgenic mice</span>
###xml 888 892 <span type="species:ncbi:10090">mice</span>
Then, we fed mice a test meal of 1g standard laboratory chow containing sugars and lipids. The difference in the thermogenic response between the two groups was amplified (Fig. 3). Pre-meal metabolic rate, respiratory quotient, and glucose and lipid oxidation were similar in wild-type and GLUT2-loop transgenic mice. The peak response of the respiratory quotient to the meal was slightly smaller in amplitude and occurred three hours later in transgenic mice than in wild-type mice. The overall increase in metabolic rate during the test meal was significantly larger in GLUT2-loop mice than in wild-type mice (3.2+/-0.3 versus 2.0+/-0.2 kJ, p<0.02), but the increase in respiratory quotient was smaller in transgenic mice than in wild-type mice (Fig. 3A and B). This phenomenon resulted from a lower level of post-meal inhibition of lipid oxidation in transgenic mice than in wild-type mice; post-meal glucose oxidation was not different between groups (Fig. 3C).
###end p 33
###begin p 34
###xml 309 316 309 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001288-g003">Fig. 3B</xref>
###xml 112 116 <span type="species:ncbi:10090">mice</span>
###xml 254 269 <span type="species:ncbi:10090">transgenic mice</span>
###xml 295 299 <span type="species:ncbi:10090">mice</span>
###xml 389 393 <span type="species:ncbi:10090">mice</span>
###xml 405 420 <span type="species:ncbi:10090">transgenic mice</span>
We estimated the basal metabolic rate between 5:00 and 7:30 a.m. at the end of the calorimetry session when the mice were in a post-absorptive/fasting state. Basal metabolic rate was similar between groups, but respiratory quotient was slightly lower in transgenic mice (0.8W) than in wild-type mice (0.84W) (Fig. 3B). We calculated that lipids fueled 60% of basal metabolism in wild-type mice and 70% in transgenic mice.
###end p 34
###begin p 35
###xml 17 32 <span type="species:ncbi:10090">transgenic mice</span>
###xml 86 90 <span type="species:ncbi:10090">mice</span>
Thus, GLUT2-loop transgenic mice had lower levels of glucose oxidation than wild-type mice but higher levels of lipid oxidation.
###end p 35
###begin title 36
Attenuated response to low and high glucose levels
###end title 36
###begin p 37
###xml 220 227 220 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001288-g004">Fig. 4A</xref>
###xml 355 362 355 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001288-g004">Fig. 4A</xref>
###xml 483 490 483 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001288-g003">Fig. 3C</xref>
###xml 562 569 562 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001288-g004">Fig. 4B</xref>
###xml 676 683 676 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001288-g004">Fig. 4B</xref>
###xml 764 771 764 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001288-g004">Fig. 4B</xref>
###xml 879 886 879 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001288-g003">Fig. 3C</xref>
###xml 26 30 <span type="species:ncbi:10090">mice</span>
###xml 164 168 <span type="species:ncbi:10090">mice</span>
###xml 203 218 <span type="species:ncbi:10090">transgenic mice</span>
###xml 315 330 <span type="species:ncbi:10090">transgenic mice</span>
###xml 349 353 <span type="species:ncbi:10090">mice</span>
###xml 466 481 <span type="species:ncbi:10090">transgenic mice</span>
###xml 636 651 <span type="species:ncbi:10090">transgenic mice</span>
###xml 670 674 <span type="species:ncbi:10090">mice</span>
###xml 758 762 <span type="species:ncbi:10090">mice</span>
###xml 862 877 <span type="species:ncbi:10090">transgenic mice</span>
We tested the capacity of mice with impaired GLUT2-mediated sugar sensing to detect sugar deficit. After 48h of fasting, the glycogen content in liver of wild-type mice was lower than taht of GLUT2-loop transgenic mice (Fig. 4A). Residual glycogen stores were larger after fasting in liver, kidney and intestine of transgenic mice than of wild-type mice (Fig. 4A), possibly resulting from the slight but constant lower rate of glucose oxidation in fasted GLUT2-loop transgenic mice (Fig. 3C). This phenomenon occurred despite normal blood glucose concentration (Fig. 4B), but was probably associated with higher plasma insulin level in transgenic mice than in wild-type mice (Fig. 4B). Total body fat content was lower in transgenic than in wild-type fasted mice (Fig. 4B). This finding may be related to the higher level of fat oxidation observed in the fasted transgenic mice (Fig. 3C).
###end p 37
###begin title 38
Detection of low and high glucose levels.
###end title 38
###begin p 39
###xml 111 115 <span type="species:ncbi:10090">mice</span>
###xml 182 186 <span type="species:ncbi:10090">mice</span>
###xml 233 237 <span type="species:ncbi:10090">mice</span>
###xml 303 307 <span type="species:ncbi:10090">mice</span>
###xml 403 418 <span type="species:ncbi:10090">transgenic mice</span>
###xml 622 637 <span type="species:ncbi:10090">transgenic mice</span>
###xml 708 712 <span type="species:ncbi:10090">mice</span>
###xml 778 782 <span type="species:ncbi:10090">mice</span>
###xml 969 984 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1080 1084 <span type="species:ncbi:10090">mice</span>
###xml 1142 1146 <span type="species:ncbi:10090">mice</span>
###xml 1284 1299 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1371 1375 <span type="species:ncbi:10090">mice</span>
###xml 1441 1445 <span type="species:ncbi:10090">mice</span>
###xml 1606 1610 <span type="species:ncbi:10090">mice</span>
###xml 1710 1714 <span type="species:ncbi:10090">mice</span>
A: Left panel: glycogen content in liver, kidney and intestine from fasting wild-type (WT) and transgenic (Tg) mice. Values are presented as means+/-S.E.M. (for the liver n = 6 to 7 mice per group, for the kidney and intestine n = 3 mice/group). Statistical differences between transgenic and wild-type mice are indicated as *P<0.05. Right panel: Representative pancreas sections from fed wild-type and transgenic mice stained with PAS reagent. The black bar corresponds to 50 microm. B: Fasting metabolic parameters. Blood glucose concentration, plasma insulin concentration and total fat are indicated for wild-type and transgenic mice after fasting for 48 h. Values are presented as means+/-S.E.M. (n = 4 mice/group). Statistical differences between transgenic and wild-type mice are indicated as *P<0.05 and ns non significant. Right panel: Example of a DEXA scan. C: Lipid metabolism. Plasma free-fatty acids (FFA) and triglyceride concentrations in wild-type and transgenic mice in the fasting state or 6h after refeeding. Values are presented as means+/-S.E.M. (n = 3 to 5 mice/group). Statistical differences between refed and fasted mice are indicated as ***P<0.001, *P<0.05 and ns non significant. Right panel: Liver triglyceride content in liver extract from wild-type and transgenic mice 6h after refeeding. Values are presented as means+/-S.E.M. (n = 4 to 5 mice/group). Statistical differences between transgenic and wild-type mice are indicated as **P<0.01. D: Blood glucose and urine glucose levels measured after steptozotocin injection. Values are presented as means+/-S.E.M. (n = 3 to 4 mice/group). Statistical differences between wild-type (open squares) and transgenic (closed triangles) mice are indicated as *P<0.05, **P<0.01.
###end p 39
###begin p 40
###xml 127 134 127 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001288-g004">Fig. 4C</xref>
###xml 236 243 236 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001288-g004">Fig. 4C</xref>
###xml 525 532 525 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001288-g004">Fig. 4C</xref>
###xml 67 71 <span type="species:ncbi:10090">mice</span>
###xml 317 332 <span type="species:ncbi:10090">transgenic mice</span>
###xml 418 433 <span type="species:ncbi:10090">transgenic mice</span>
###xml 508 523 <span type="species:ncbi:10090">transgenic mice</span>
Plasma free fatty acids (FFA) levels were high in fasted wild-type mice, and plasma triglyceride levels were low, as expected (Fig. 4C). Plasma FFA levels were lower and plasma triglyceride levels were higher six hours after refeeding (Fig. 4C). We observed a similar, but attenuated profile for plasma FFA levels in transgenic mice, but plasma triglyceride levels were not significantly different in refed and fasted transgenic mice. Consequently, the triglyceride content remained high in the liver of fed transgenic mice (Fig. 4C).
###end p 40
###begin p 41
###xml 39 54 <span type="species:ncbi:10090">transgenic mice</span>
###xml 100 104 <span type="species:ncbi:10090">mice</span>
###xml 123 138 <span type="species:ncbi:10090">transgenic mice</span>
This finding indicates that GLUT2-loop transgenic mice are more resistant to fasting than wild-type mice and suggests that transgenic mice do not properly detect sugar deficit.
###end p 41
###begin p 42
###xml 217 224 216 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001288-g004">Fig. 4D</xref>
###xml 440 447 439 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001288-g004">Fig. 4D</xref>
###xml 177 192 <span type="species:ncbi:10090">transgenic mice</span>
###xml 211 215 <span type="species:ncbi:10090">mice</span>
###xml 390 394 <span type="species:ncbi:10090">mice</span>
Injection of streptozotocin (a drug that poisons pancreatic ss-cells) led to pronounced hyperglycemia. We observed significantly less pronounced hyperglycemia and glucosuria in transgenic mice than in wild-type mice (Fig. 4D) the day after drug injection. However, the protection against streptozotocin-induced diabetes was transient, as blood and urine glucose levels in the two groups of mice were the same two days after drug injection (Fig. 4D).
###end p 42
###begin title 43
Glucose tolerance and pancreatic functions
###end title 43
###begin p 44
###xml 176 183 176 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001288-g005">Fig. 5A</xref>
###xml 229 236 229 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001288-g005">Fig. 5A</xref>
###xml 733 740 733 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001288-g005">Fig. 5B</xref>
###xml 159 174 <span type="species:ncbi:10090">transgenic mice</span>
###xml 316 331 <span type="species:ncbi:10090">transgenic mice</span>
###xml 431 435 <span type="species:ncbi:10090">mice</span>
###xml 574 589 <span type="species:ncbi:10090">transgenic mice</span>
###xml 678 693 <span type="species:ncbi:10090">transgenic mice</span>
Glucose modulates many pancreatic functions. We verified that the regulation of a subset of glucose-sensitive genes was impaired in the pancreas of GLUT2-loop transgenic mice (Fig. 5A). In the pancreas, mRNA of GLUT2 and ChREBP (Fig. 5A) and glucokinase (not shown) accumulated significantly in wild-type but not in transgenic mice, 2 h after an oral glucose load. We observed similar accumulation of ACC mRNA in the two groups of mice (not shown). These findings suggest that glucose detection in the pancreas, as measured by the stimulation of target genes, is altered in transgenic mice. GLUT2 protein levels were similar in pancreas membrane preparations from wild-type and transgenic mice fed a glucose-rich diet for five days (Fig. 5B).
###end p 44
###begin title 45
###xml 23 27 <span type="species:ncbi:10090">mice</span>
Pancreatic function in mice after impairment of extracellular sugar detection.
###end title 45
###begin p 46
###xml 106 110 <span type="species:ncbi:10090">mice</span>
###xml 244 248 <span type="species:ncbi:10090">mice</span>
###xml 306 310 <span type="species:ncbi:10090">mice</span>
###xml 433 437 <span type="species:ncbi:10090">mice</span>
###xml 576 591 <span type="species:ncbi:10090">transgenic mice</span>
###xml 630 634 <span type="species:ncbi:10090">mice</span>
###xml 651 666 <span type="species:ncbi:10090">transgenic mice</span>
###xml 726 730 <span type="species:ncbi:10090">mice</span>
###xml 898 913 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1036 1040 <span type="species:ncbi:10090">mice</span>
###xml 1157 1172 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1187 1191 <span type="species:ncbi:10090">mice</span>
###xml 1257 1261 <span type="species:ncbi:10090">mice</span>
###xml 1381 1385 <span type="species:ncbi:10090">mice</span>
###xml 1470 1474 <span type="species:ncbi:10090">mice</span>
###xml 1540 1544 <span type="species:ncbi:10090">mice</span>
###xml 1690 1705 <span type="species:ncbi:10090">transgenic mice</span>
###xml 2002 2006 <span type="species:ncbi:10090">mice</span>
A: Effect of a glucose-rich diet on gene expression in the pancreas of wild-type (WT) and transgenic (Tg) mice fasted for 48h and refed for 15 h. Levels of mRNA were analyzed by real-time PCR. Values are presented as means+/-S.E.M. (n = 3 to 4 mice/group). Statistical differences between refed and fasted mice are indicated as **P<0.01 and ns non significant. B: GLUT2 protein levels in total membrane preparations of pancreas from mice fed a glucose-rich diet for five days. C: Left panel: Blood glucose concentrations during an oral glucose tolerance test in wild-type and transgenic mice fasted for 24 h (n = 17 for wild-type mice, n = 2 to 5 for transgenic mice). Statistical differences between transgenic and wild-type mice are indicated as ***P<0.001, *P<0.05 and ns non significant (two-way ANOVA) for the areas under the curves. Right panel: Blood glucose concentrations in wild-type and transgenic mice in the fasted state or 6 h after being refed with a glucose-rich diet. Values are presented as means+/-S.E.M. (n = 4 to 8 mice/group). D: Upper panel: Plasma insulin concentrations during an oral glucose tolerance test in fasted wild-type and transgenic mice (n = 10 to 13 mice/group). Statistical differences between transgenic and wild-type mice are indicated as ***P<0.001 (two-way ANOVA) for the areas under the curves. Lower panel: Pancreatic insulin content in mice 6h after being refed a standard diet. Values are presented as means+/-S.E.M. (n = 5 mice/group). Statistical differences between transgenic and wild-type mice are indicated as *P<0.05. E: Upper panel : Representative immunostaining with antibody against insulin of pancreatic sections from wild-type and transgenic mice. Arrows indicate small islets. The bar corresponds to 100 microm. Lower panel: Histomorphometric comparisons of islet number, size and ss-cell mass. Proportion of small islets (<25 microm) to total number of islets is statistically different indicated as *P<0.03 between transgenic and wild-type mice.
###end p 46
###begin p 47
###xml 172 179 172 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001288-g005">Fig. 5C</xref>
###xml 284 291 284 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001288-g003">Fig. 3C</xref>
###xml 377 384 377 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001288-g005">Fig. 5C</xref>
###xml 505 512 505 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001288-g005">Fig. 5C</xref>
###xml 100 115 <span type="species:ncbi:10090">transgenic mice</span>
###xml 134 138 <span type="species:ncbi:10090">mice</span>
###xml 278 282 <span type="species:ncbi:10090">mice</span>
###xml 364 369 <span type="species:ncbi:10090">mouse</span>
###xml 499 503 <span type="species:ncbi:10090">mice</span>
###xml 549 564 <span type="species:ncbi:10090">transgenic mice</span>
###xml 629 633 <span type="species:ncbi:10090">mice</span>
Blood glucose concentrations during an oral glucose tolerance test remained significantly higher in transgenic mice than in wild-type mice, indicating glucose intolerance (Fig. 5C). This occurred despite glucose and lipid oxidation having the same kinetics in the two groups of mice (Fig. 3C). Nevertheless, we observed glucose intolerance in all three transgenic mouse lines (Fig. 5C). Six hours after being refed a glucose-rich diet, blood glucose concentrations were similar in the two groups of mice (Fig. 5C). This indicates that after a delay transgenic mice can regulate blood glucose concentration similarly to wild-type mice.
###end p 47
###begin p 48
###xml 129 136 129 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001288-g005">Fig. 5D</xref>
###xml 374 381 374 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001288-g005">Fig. 5D</xref>
###xml 89 104 <span type="species:ncbi:10090">transgenic mice</span>
###xml 123 127 <span type="species:ncbi:10090">mice</span>
###xml 286 301 <span type="species:ncbi:10090">transgenic mice</span>
###xml 320 324 <span type="species:ncbi:10090">mice</span>
Plasma insulin levels during the glucose load remained significantly lower in GLUT2-loop transgenic mice than in wild-type mice (Fig. 5D). Thus, a defective insulin response to oral glucose may explain, at least in part, glucose intolerance. Pancreatic insulin content was 30% lower in transgenic mice than in wild-type mice six hours after being refed a glucose-rich diet (Fig. 5D). Impairment of glucose detection by GLUT2 in the pancreas attenuated changes in insulin production in response to glucose or to diet.
###end p 48
###begin p 49
###xml 170 185 <span type="species:ncbi:10090">transgenic mice</span>
###xml 247 251 <span type="species:ncbi:10090">mice</span>
###xml 331 346 <span type="species:ncbi:10090">transgenic mice</span>
Insulin production is regulated by glucose at various steps. Proinsulin mRNA accumulation was 2.9+/-0.5 times higher in wild-type and 2.3+/-0.3 times higher (p = 0.3) in transgenic mice fed a high-glucose diet for two hours than in fasted control mice. These findings together with the lower insulin protein content in pancreas of transgenic mice suggest that a GLUT2-mediated glucose detection step is involved in the translation or maturation of insulin.
###end p 49
###begin p 50
###xml 140 141 140 141 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 208 215 208 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001288-g005">Fig. 5E</xref>
###xml 394 401 390 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001288-g005">Fig. 5E</xref>
###xml 555 562 551 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001288-g005">Fig. 5D</xref>
###xml 145 160 <span type="species:ncbi:10090">transgenic mice</span>
###xml 202 206 <span type="species:ncbi:10090">mice</span>
###xml 343 358 <span type="species:ncbi:10090">transgenic mice</span>
###xml 377 381 <span type="species:ncbi:10090">mice</span>
###xml 487 502 <span type="species:ncbi:10090">transgenic mice</span>
###xml 521 525 <span type="species:ncbi:10090">mice</span>
We therefore analyzed the morphology of pancreatic islets. Immunohistochemical and morphometrical analyses showed that total islet number/mm2 of transgenic mice was not different from that of wild-type mice (Fig. 5E). However, the proportion of insulin-labeled cells organized as small islets (<25 microm) was higher in pancreas of GLUT2-loop transgenic mice than of wild-type mice (p = 0.03) (Fig. 5E). This finding is consistent with the lower pancreatic insulin content in GLUT2-loop transgenic mice than in wild-type mice six hours after being refed (Fig. 5D).
###end p 50
###begin p 51
###xml 269 284 <span type="species:ncbi:10090">transgenic mice</span>
The invalidation of GLUT2-mediated glucose detection in pancreatic ss-cells impaired insulin production, but did not modify GLUT2 protein level and insulin mRNA accumulation. Though islet morphology appeared preserved, insulin-positive cell organization was altered in transgenic mice.
###end p 51
###begin title 52
Excretion of excess glucose by the kidney
###end title 52
###begin p 53
###xml 208 223 <span type="species:ncbi:10090">transgenic mice</span>
Besides the insulin action on peripheral tissues, excess glucose is efficiently cleared from blood by renal excretion. We thus analyzed the role of GLUT2-mediated extracellular glucose detection in kidney of transgenic mice.
###end p 53
###begin p 54
###xml 251 258 251 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001288-g006">Fig. 6A</xref>
###xml 469 476 469 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001288-g006">Fig. 6B</xref>
###xml 74 89 <span type="species:ncbi:10090">transgenic mice</span>
###xml 111 115 <span type="species:ncbi:10090">mice</span>
###xml 234 249 <span type="species:ncbi:10090">transgenic mice</span>
###xml 349 364 <span type="species:ncbi:10090">transgenic mice</span>
###xml 438 453 <span type="species:ncbi:10090">transgenic mice</span>
###xml 551 566 <span type="species:ncbi:10090">transgenic mice</span>
We verified that GLUT2-mediated sugar detection was impaired in kidney of transgenic mice. Unlike in wild-type mice, consumption of a glucose-rich diet after 48 h of fasting did not lead to accumulation of GLUT2 and SREBP-1c mRNAs in transgenic mice (Fig. 6A and not shown). Basal levels of these mRNAs were not different in kidney of wild-type and transgenic mice and the GLUT2 protein levels in membrane preparations from wild-type and transgenic mice were the same (Fig. 6B). The lack of glucose-stimulated gene expression confirmed that kidney of transgenic mice did not properly detect extracellular glucose concentration.
###end p 54
###begin title 55
###xml 19 23 <span type="species:ncbi:10090">mice</span>
Kidney function in mice after impairment of extracellular sugar detection.
###end title 55
###begin p 56
###xml 104 108 <span type="species:ncbi:10090">mice</span>
###xml 243 247 <span type="species:ncbi:10090">mice</span>
###xml 305 309 <span type="species:ncbi:10090">mice</span>
###xml 439 443 <span type="species:ncbi:10090">mice</span>
###xml 548 563 <span type="species:ncbi:10090">transgenic mice</span>
###xml 722 737 <span type="species:ncbi:10090">transgenic mice</span>
###xml 745 749 <span type="species:ncbi:10090">mice</span>
###xml 819 823 <span type="species:ncbi:10090">mice</span>
###xml 1004 1008 <span type="species:ncbi:10090">mice</span>
###xml 1066 1070 <span type="species:ncbi:10090">mice</span>
A: Effect of a glucose-rich diet on gene expression in the kidney of transgenic (Tg) and wild-type (WT) mice fasted for 48 h and refed for 15 h. Levels of mRNA were analyzed by real-time PCR. Values are presented as means+/-S.E.M. (n = 3 to 4 mice/group). Statistical differences between refed and fasted mice are indicated as *P<0.05, **P<0.01 and ns non significant. B: GLUT2 protein levels in total membrane preparations of kidney from mice fed with a glucose-rich diet for five days. C: Structure, size and weight of kidneys from wild-type and transgenic mice shown by ultrasonic image (transverse cross section). D: Urine and blood glucose concentrations during an oral glucose tolerance test in fasted wild-type and transgenic mice (n = 3 mice per group). Statistical differences between transgenic and wild-type mice are indicated as **P<0.01 (two-way ANOVA) for the areas under the curves. E: Levels of SGLT mRNA were analyzed by real-time PCR. Values are presented as means+/-S.E.M. (n = 3 to 4 mice/group). Statistical differences between refed and fasted mice are indicated as **P<0.01 and ns non significant.
###end p 56
###begin p 57
###xml 217 224 217 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001288-g006">Fig. 6C</xref>
###xml 371 378 371 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001288-g006">Fig. 6C</xref>
###xml 383 385 383 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001288-g003">3A</xref>
###xml 148 163 <span type="species:ncbi:10090">transgenic mice</span>
We assessed the consequences of impaired GLUT2-mediated glucose detection in the kidney by examining kidney structure by echography. The kidneys of transgenic mice were 160% larger in diameter than wild-type kidneys (Fig. 6C), although they had similar weights. We observed a difference in echogenicity due to glycogen but not to water accumulation in transgenic kidney (Fig. 6C and 3A).
###end p 57
###begin p 58
###xml 262 269 262 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001288-t001">Table 1</xref>
###xml 426 433 426 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001288-t001">Table 1</xref>
###xml 611 618 611 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001288-g006">Fig. 6D</xref>
###xml 863 870 859 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001288-g006">Fig. 6D</xref>
###xml 231 235 <span type="species:ncbi:10090">mice</span>
###xml 386 401 <span type="species:ncbi:10090">transgenic mice</span>
###xml 420 424 <span type="species:ncbi:10090">mice</span>
###xml 525 540 <span type="species:ncbi:10090">transgenic mice</span>
###xml 601 605 <span type="species:ncbi:10090">mice</span>
###xml 677 681 <span type="species:ncbi:10090">mice</span>
###xml 837 852 <span type="species:ncbi:10090">transgenic mice</span>
###xml 917 932 <span type="species:ncbi:10090">transgenic mice</span>
###xml 951 955 <span type="species:ncbi:10090">mice</span>
###xml 1011 1026 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1045 1049 <span type="species:ncbi:10090">mice</span>
The ratio of urine volume excreted to the water volume consumed per day was identical in the two groups (not shown). We analyzed the urine composition and found that the measured parameters did not differ between the two groups if mice were fed a standard diet (Table 1). In contrast, the consumption of a glucose-rich diet led to significantly greater urine glucose loss in GLUT2-loop transgenic mice than in wild-type mice (Table 1). We used an oral glucose load to document this specific loss of glucose in the urine. The transgenic mice lost substantially more glucose in the urine than wild-type mice did (Fig. 6D). Moreover, we detected glucose in the urine of wild-type mice when the blood glucose concentration reached 200+/-10mg/dl, whereas glucosuria appeared as soon as the blood glucose concentration reached 170+/-4mg/dl in transgenic mice (p<0.03) (Fig. 6D). This indicates a lower glucose threshold in transgenic mice than in wild-type mice. We observed a significantly lower SGLT1 mRNA level in transgenic mice than in wild-type mice 15 hours after being refed, whereas SGLT2 mRNA levels were similar in the two groups. These findings suggest that impairment of glucose detection provoked major adaptation in glucose renal reabsorption.
###end p 58
###begin title 59
###xml 21 25 <span type="species:ncbi:10090">mice</span>
###xml 155 170 <span type="species:ncbi:10090">transgenic mice</span>
###xml 314 329 <span type="species:ncbi:10090">transgenic mice</span>
Urinary excretion in mice after impairment of extracellular sugar detection. Metabolic and electrolyte levels in 24-h urine samples from wild-type (WT) or transgenic mice fed a standard or a glucose-rich diet. Values are presented as means+/-S.E.M. (n = 6 per group). Statistical differences between wild-type and transgenic mice are indicated as *P<0.05 ns non significant, nd indicates not determined.
###end title 59
###begin title 60
Discussion
###end title 60
###begin p 61
###xml 735 739 735 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Guillam1">[10]</xref>
###xml 741 745 741 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Guillam2">[15]</xref>
###xml 124 139 <span type="species:ncbi:10090">Transgenic mice</span>
###xml 534 538 <span type="species:ncbi:10090">mice</span>
###xml 635 639 <span type="species:ncbi:10090">mice</span>
###xml 775 790 <span type="species:ncbi:10090">transgenic mice</span>
In this study, we show that prevention of sugar detection strongly affects many mechanisms involved in glucose homeostasis. Transgenic mice excreted massive amount of glucose in urine, which protected them against excess glucose despite attenuated pancreatic insulin production and a preference for lipid oxidation over glucose oxidation. The GLUT2 loop, used here as a molecular tool, blocked the sugar detection triggered by GLUT2 without affecting basal mRNA levels in liver, kidney and pancreas. On the other hand, the GLUT2-null mice, in which both sugar entry and sugar detection are invalidated, deteriorates after weaning, and mice die probably because they are unable to handle excess glucose by appropriate insulin secretion [10], [15]. The phenotype of GLUT2-loop transgenic mice may be related to the maintenance of glucose- and insulin-sensitive functions at basal levels.
###end p 61
###begin p 62
###xml 427 431 427 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Meugnier1">[17]</xref>
###xml 680 695 <span type="species:ncbi:10090">transgenic mice</span>
The expression of the GLUT2-loop transgene interfered with GLUT2-triggered glucose detection. This highlights the efficiency of this plasma membrane chemoreceptor for glucose, and provides a new therapeutic target for glucose homeostasis. Consumption of a glucose-rich diet still led to accumulation of target gene mRNA in adipose tissue. Indeed, hyperglycemia-modulated gene expression has been reported in peripheral tissues [17]. In tissues without GLUT2, glucose detection occurred by GLUT2-independent mechanisms, probably due to "intracellular" metabolism. As expected, these mechanisms were not directly affected by the molecular tool (GLUT2 loop). Accordingly, GLUT2-loop transgenic mice had normal insulin sensitivity in peripheral tissues, mainly muscle and adipose tissue. The capacity of peripheral tissues to respond to insulin remained unaffected by the expression of the transgene.
###end p 62
###begin p 63
###xml 110 125 <span type="species:ncbi:10090">transgenic mice</span>
The amount of GLUT2 protein in the membranes of liver, pancreas and kidney cells showed that the phenotype of transgenic mice was not caused by defective glucose entry into the cells but rather by the inability of the cells to detect extracellular glucose.
###end p 63
###begin p 64
###xml 389 393 389 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-YvanCharvet1">[18]</xref>
###xml 470 474 470 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Teegarden1">[19]</xref>
###xml 43 58 <span type="species:ncbi:10090">transgenic mice</span>
###xml 123 138 <span type="species:ncbi:10090">transgenic mice</span>
###xml 233 237 <span type="species:ncbi:10090">mice</span>
###xml 269 284 <span type="species:ncbi:10090">transgenic mice</span>
###xml 320 324 <span type="species:ncbi:10090">mice</span>
###xml 504 519 <span type="species:ncbi:10090">transgenic mice</span>
A fundamental characteristic of GLUT2-loop transgenic mice was that basal metabolism remained unaffected. Nevertheless, in transgenic mice fed with the usual diet, thermic response occurred but was two times slower than in wild-type mice. Fuel oxidation indicated that transgenic mice utilize more lipids than wild-type mice. Better lipid oxidation improves resistance to high fat feeding [18] and increases weight and fat losses without major changes in lean body mass [19], a feature observed in these transgenic mice.
###end p 64
###begin p 65
###xml 10 14 <span type="species:ncbi:10090">mice</span>
###xml 62 77 <span type="species:ncbi:10090">transgenic mice</span>
###xml 269 273 <span type="species:ncbi:10090">mice</span>
###xml 452 467 <span type="species:ncbi:10090">transgenic mice</span>
###xml 601 605 <span type="species:ncbi:10090">mice</span>
Wild-type mice use their energy stores during fasting whereas transgenic mice protect their energy stores when deprived of food due to an impaired ability to detect changes in glucose levels. The slower mobilization of glycogen stores in transgenic compared to control mice is probably due to plasma insulin, which remained high during fasting, and to the preference for lipid oxidation over glucose oxidation. Partial preservation of energy stores in transgenic mice occurred despite similar levels of circulating glucose, suggesting that low glucose concentration was inadequately detected in these mice.
###end p 65
###begin p 66
###xml 169 173 168 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Szkudelski1">[20]</xref>
Transient protection against streptozotocin-induced diabetes has been observed possibly due to many GLUT2-mediated effects, including drug access to pancreatic ss cells [20], but not to accelerated urinary glucose loss or larger stores of pancreatic insulin.
###end p 66
###begin p 67
Therefore, we concluded that GLUT2-expressing tissues involved in glucose homeostasis poorly detected both high and low glucose levels.
###end p 67
###begin title 68
Pancreatic adaptations to impaired detection of extracellular glucose
###end title 68
###begin p 69
###xml 91 94 91 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Schuit1">[3]</xref>
###xml 325 329 324 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Wang1">[21]</xref>
###xml 789 793 788 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Giddings1">[22]</xref>
###xml 801 809 800 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 875 879 874 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Itoh1">[23]</xref>
###xml 881 885 880 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Schuit2">[24]</xref>
###xml 887 891 886 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Skelly1">[25]</xref>
###xml 893 897 892 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Wicksteed1">[26]</xref>
###xml 970 974 969 973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Nielsen1">[27]</xref>
###xml 994 998 993 997 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Welsh1">[28]</xref>
###xml 1150 1154 1148 1152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Skelly1">[25]</xref>
###xml 1156 1160 1154 1158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Wicksteed1">[26]</xref>
###xml 1162 1166 1160 1164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Wang1">[21]</xref>
###xml 359 374 <span type="species:ncbi:10090">transgenic mice</span>
###xml 430 434 <span type="species:ncbi:10090">mice</span>
###xml 723 727 <span type="species:ncbi:10090">mice</span>
###xml 784 788 <span type="species:ncbi:10090">mice</span>
Pancreatic glucose sensing is mediated by metabolism and primarily by glucokinase activity [3]. How glucokinase activity is translated into a quantitative signal remains unknown. It has been reported that after being metabolized in the ss-cell, glucose stimulates insulin gene transcription by a mechanism involving SREBP-1c [21]. Insulin mRNA accumulated in transgenic mice after consumption of a glucose-rich diet as in control mice. Thus, GLUT2-mediated glucose sensing did not significantly alter transcription and stability of insulin mRNA. Nevertheless, transgenic pancreas had low insulin content, consistent with reports showing that insulin expression is also regulated by glucose at a translational level. Fasted mice had lower islet insulin mRNA content as compared to fed mice [22]. While in vitro the acute changes in glucose affected mainly insulin translation [23], [24], [25], [26], chronic changes in glucose impacted on both insulin gene transcription [27] and mRNA stability [28]. In ss-cell, long term glucose sets the preproinsulin mRNA level whereas short term glucose regulates the translation rates of proinsulin biosynthesis [25], [26], [21].
###end p 69
###begin p 70
###xml 254 258 252 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Chick1">[29]</xref>
###xml 259 263 257 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Pth1">[32]</xref>
###xml 309 313 307 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Hoorens1">[33]</xref>
###xml 315 319 313 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Bernard2">[34]</xref>
###xml 454 458 451 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Poitout1">[35]</xref>
###xml 460 464 457 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Robertson1">[36]</xref>
###xml 489 493 486 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Kaiser1">[37]</xref>
###xml 827 831 817 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Otani1">[38]</xref>
###xml 853 857 843 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Dai1">[39]</xref>
###xml 928 932 917 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Heit1">[40]</xref>
###xml 41 56 <span type="species:ncbi:10090">transgenic mice</span>
###xml 596 611 <span type="species:ncbi:10090">transgenic mice</span>
###xml 770 774 <span type="species:ncbi:10090">mice</span>
###xml 848 852 <span type="species:ncbi:10090">mice</span>
Decreased insulin content in pancreas of transgenic mice may thus result from small ss-cell mass and increased number of small islets compared to controls. Supporting this idea, pancreatic ss-cell expansion is induced by glucose-stimulated proliferation [29]-[32], and glucose-mediated reduction of apoptosis [33], [34]. However, glucotoxicity has been linked to persistent hyperglycemia in type II diabetes as a result of impaired ss-cell proliferation [35], [36] and increased apoptosis [37]. Plasma insulin concentration did not increase adequately in response to a glucose load in GLUT2-loop transgenic mice suggesting that GLUT2-mediated glucose detection is necessary for normal ss-cell development and function. A reduced beta cell mass has also been reported in mice, lacking insulin receptors in pancreatic beta-cells [38], and in HGFR KO mice [39], suggesting that there are many regulators of pancreatic ss cell mass [40]. Some of these regulators may be under the control of GLUT2-mediated sugar detection. Further investigation with a broader analysis, is necessary to resolve this question.
###end p 70
###begin title 71
Kidney adaptations to impaired detection of extracellular glucose
###end title 71
###begin p 72
###xml 347 351 347 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Izzedine1">[41]</xref>
###xml 615 619 615 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Berry1">[42]</xref>
###xml 715 719 715 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Santer1">[11]</xref>
###xml 1644 1648 1644 1648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Wright1">[43]</xref>
###xml 468 476 <span type="species:ncbi:9606">patients</span>
###xml 706 714 <span type="species:ncbi:9606">patients</span>
###xml 787 802 <span type="species:ncbi:10090">transgenic mice</span>
###xml 972 987 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1142 1157 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1203 1207 <span type="species:ncbi:10090">mice</span>
The urinary excretion of glucose observed here might be due to specific or general tubular adaptations. In the kidney, a failure of tubules to reabsorb small molecules will cause increased urinary excretion of glucose but also of amino acids, minerals, electrolytes (sodium, potassium, bicarbonate) and water as observed in renal Fanconi syndrome [41]. This will result in polyuria, polydipsia, dehydration, hypophosphatemic rickets and growth retardation. Similarly, patients affected by GLUT2 mutation do not reabsorb glucose and various filtered solutes because of impairment in GLUT2-mediated efflux of glucose [42]. Accumulation of glycogen in renal tubular cells has been described in Fanconi-Bickel patients [11]. Glycogen deposit is maintained in the kidney of fasted GLUT2-loop transgenic mice but there was no perturbation of basal kidney function. Such perturbation appeared only after oral glucose load or the consumption of a glucose-rich diet. In GLUT2-loop transgenic mice, normal reabsorption of glucose and associated solutes occurred when blood glucose levels were under 170 mg/dl. Glucose reabsorption is not sufficient in transgenic mice and the threshold is lower than in wild-type mice, but there was no significant electrolyte loss. The renal adaptations related to GLUT2-mediated sugar detection are restricted here to decreased glucose reabsorption. We found a relationship in kidney between glucose detection by GLUT2 and the decrease in SGLT1 mRNA. Mutations in SGLT1 gene provokes glucose-galactose malabsorption accompanied by mild glucosuria whereas familial renal glucosuria is due to mutations in the SGLT2 gene [43]. Several proteins of proximal tubule and their regulators are likely to be involved in the process of glucose tubular reabsorption. Thus, further investigation is required to understand the molecular mechanisms for this renal functional adaptation.
###end p 72
###begin p 73
###xml 306 310 302 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Menzel1">[44]</xref>
###xml 494 498 486 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Pontoglio1">[45]</xref>
###xml 4 9 <span type="species:ncbi:10090">mouse</span>
###xml 184 192 <span type="species:ncbi:9606">patients</span>
###xml 361 369 <span type="species:ncbi:9606">patients</span>
###xml 392 396 <span type="species:ncbi:10090">mice</span>
###xml 528 543 <span type="species:ncbi:10090">transgenic mice</span>
###xml 560 564 <span type="species:ncbi:10090">mice</span>
###xml 757 761 <span type="species:ncbi:10090">mice</span>
The mouse phenotype described here, characterized by a low level of insulin secretion and a high level of glucosuria, is reminiscent of a monogenic (HNF1alpha) form of diabetes. MODY3 patients have a defect in insulin secretion but no obvious hyperglycemia probably related to massive urinary glucose loss [44]. The maximal renal reabsorption capacity of these patients, as in HNF1alpha-null mice, is decreased due to substantially less transcription of a sodium/glucose co-transporter (SGLT2) [45]. In contrast with GLUT2-loop transgenic mice, HNF1alpha-null mice had defective renal tubular reabsorption of various metabolites (amino acids, phosphates), in addition to glucose, suggesting that HNF1alpha levels are not involved in the defect we report in mice with an impaired detection of extracellular glucose.
###end p 73
###begin p 74
In conclusion, artificial inhibition of GLUT2-mediated sugar sensing in a limited number of tissues, modified various parameters of glucose homeostasis. This may be advantageous because urinary glucose loss can eliminate excess glucose and reduce fat deposits. Moreover, an attenuated secretion of insulin on demand can preserve pancreatic potential in the long term.
###end p 74
###begin title 75
Materials and Methods
###end title 75
###begin title 76
###xml 12 27 <span type="species:ncbi:10090">transgenic mice</span>
Creation of transgenic mice
###end title 76
###begin p 77
###xml 198 202 198 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Niwa1">[46]</xref>
###xml 398 402 398 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Guillemain1">[12]</xref>
The actin promoter was used to drive strong and ubiquitous expression of the transgene. We used pCAGGS-IRES2-EGFP (kindly provided by MR Hirsh), derived from the pCAGGS eukaryotic expression vector [46]. We replaced the internal ribosome entry site (IRES) and the enhanced green fluorescent protein (EGFP) gene with the EGFP-Loop DNA fragment coding for amino acids 237 to 301 previously described [12].
###end p 77
###begin p 78
###xml 14 29 <span type="species:ncbi:10090">transgenic mice</span>
Genotyping of transgenic mice was carried out by PCR with a forward primer recognizing EGFP (5'-CGAATTCCTGTCCAGAAAGCC-3') and a reverse primer recognizing the GLUT2 loop (5'-AGAAGTCAGATGCTCAAGGGG-3'). The transgene copy number was determined by real-time PCR with the same primers. Apolipoprotein A1 was used as a reference (primers from A. Kalopissis).
###end p 78
###begin p 79
###xml 228 243 <span type="species:ncbi:10090">transgenic mice</span>
The animals were bred in the transgenic animal facilities of IFR58 (Paris). All animal procedures complied with published recommendations for the use of laboratory animals by the French government. Tg B , Tg P and Tg G indicate transgenic mice from the B, P and G lines, respectively.
###end p 79
###begin title 80
Analysis of metabolic parameters
###end title 80
###begin p 81
###xml 56 60 <span type="species:ncbi:10090">mice</span>
###xml 259 264 <span type="species:ncbi:10090">mouse</span>
###xml 283 286 <span type="species:ncbi:10116">Rat</span>
###xml 287 292 <span type="species:ncbi:10090">Mouse</span>
Blood samples were collected from the tail of conscious mice. Blood glucose concentrations were measured with a glucometer (Accu-chek Go, Roche); urinary glucose, with test strips (Keto-Diastix, Bayer); plasma insulin concentrations, with an ELISA kit with a mouse insulin standard (Rat/Mouse insulin Kit, LINCO); plasma free fatty acids (FFA) concentrations, with an NEFA C determination kit (Wako); plasma triglycerides, with a TG enzymatic determination kit (Biomerieux) and tissue glucose content, with a D-glucose/D-fructose determination kit (Boehringer Mannheim/R-Biopharm, Roche).
###end p 81
###begin p 82
Levels of urine proteins, creatinine, sodium, potassium, chloride, calcium, phosphate and glucose were measured with an automatic analyzer (Hitachi 911; Boehringer Mannheim).
###end p 82
###begin p 83
Tissue glycogen content was measured enzymatically (Roche Applied Science). Before insulin content determination, the pancreas was homogenized in an acid-alcohol solution.
###end p 83
###begin title 84
RNA extraction and quantitative PCR analyses
###end title 84
###begin p 85
###xml 672 676 668 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Dentin1">[47]</xref>
###xml 690 694 686 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Quinet1">[48]</xref>
###xml 763 767 759 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Guillemain2">[49]</xref>
Total RNA from liver, kidney, pancreas and epididymal fat pads was extracted with Tri-Reagent (MRC). Reverse transcription (RT) was carried out with 1 microg total RNA. Messenger RNA was quantified with the Light-Cycler system (Roche Molecular Biochemicals I primer, Indianapolis). Specific primers were designed for GLUT2 (Fwd: 5'-ACCCTGTTCCTAACCGGG-3', Rev: 5'-TGAACCAAGGGATTGGACC-3'), proinsulin (Fwd: 5'-AAACCCACCCAGGCTTTTGT-3', Rev: 5'-ATCCACAATGCCACGCTTCT-3') SGLT1 (Fwd: 5'-GGGTGGCTTTGAATGGAA-3', Rev: 5'-CCTTGATGTAAATCGGGACAA-3') and SGLT2 (Fwd: 5'-GCTGGATTTGAGTGGAATGC-3', Rev: 5'-CGGTCAGATACACTGGCACA-3'). Primers used to detect glucokinase, SREBP-1c and ChREBP [47], FAS and ACC [48] have been described previously. L19 was used as an internal control [49].
###end p 85
###begin title 86
Immunoblotting analysis and immunoprecipitation
###end title 86
###begin p 87
###xml 66 70 66 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-VouretCraviari1">[50]</xref>
Crude membrane preparations were obtained as previously described [50]. The membrane proteins were resolved by 12% SDS-PAGE and transferred to nitrocellulose membrane.
###end p 87
###begin p 88
Membrane proteins were analyzed by immunoblotting with antibody against the GLUT2 intracellular loop (produced by Eurogentec) and the first GLUT2 extracellular loop (Chemicon).
###end p 88
###begin p 89
###xml 273 279 <span type="species:ncbi:9986">rabbit</span>
For immunoprecipitation, frozen liver was homogenized in RIPA buffer (20 mM Tris pH7.5, 1 mM, EDTA, 0.15M NaC1, 10 mM KC1, 1%NP-40, 0.1% deoxycholate, 0.1% SDS) containing protease inhibitor cocktail (Roche) and 42 mM MG132 (Calbiochem). Liver extracts were incubated with rabbit polyclonal antibody against the GLUT2 intracellular loop and protein G-Sepharose beads. The immune complexes were analyzed by immunoblotting with the antibody against the GLUT2 loop.
###end p 89
###begin title 90
Immunohistochemical and morphometric analyses
###end title 90
###begin p 91
###xml 153 155 153 155 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nd</sup>
###xml 587 591 583 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Hull1">[51]</xref>
###xml 263 273 <span type="species:ncbi:10141">guinea pig</span>
###xml 374 380 <span type="species:ncbi:9986">rabbit</span>
###xml 386 396 <span type="species:ncbi:10141">guinea pig</span>
###xml 1297 1301 <span type="species:ncbi:10090">mice</span>
The pancreas was fixed overnight in Bouin's solution and embedded in paraffin according to standard procedures. Ten sections per pancreas, taken every 72nd serial section (6 microm thick) obtained throughout the block of pancreas, were immunostained for insulin (guinea pig anti-porcine insulin antibody, 1:500, ImmunO, MP biomedical), detected with a peroxidase-conjugated rabbit anti-guinea pig antibody (1:50, Dako) and a peroxidase substrate kit (DAB, Vector Laboratories). Tissue sections were counterstained with hematoxylin. Morphometrical analyses were performed as described in [51]. Surface area occupied by insulin staining and total pancreatic tissue were quantified with a 10x objective on a Leica microscope outfitted with a camera and the Leica Qwin software (Leica, France). The section sign-cell fraction (percent beta-cell in the pancreas) represents the ratio of insulin-positive cell area to the total pancreatic tissue area on the entire section. section sign-cell mass was calculated as the surface ratio between section sign-cell and total pancreatic tissue multiplied by pancreatic weight. The proportions of small (<25 microm), medium (>26 to <100microm), and large (>100microm) islets were also quantified. A total of 250-500 islets were counted per pancreas. At least 3 mice were analyzed per group.
###end p 91
###begin p 92
Histological sections of pancreas were incubated with Schiff reagent (Merck) for glycogen visualization.
###end p 92
###begin title 93
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
In vivo studies
###end title 93
###begin p 94
###xml 231 235 231 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Gouyon1">[52]</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were fed either a standard carbohydrate diet (23% proteins, 51% carbohydrates, 3% lipids) obtained from Dietex (Saint-Gratien, France) or a glucose-rich diet (19% casein, 0.3% methionine, 65% dextrose) as previously described [52].
###end p 94
###begin p 95
###xml 41 45 <span type="species:ncbi:10090">mice</span>
###xml 148 152 <span type="species:ncbi:10090">mice</span>
For oral glucose tolerance tests (OGTT), mice were fasted for 24 h and then received a glucose load of 3.6 g/kg. For insulin tolerance tests (ITT), mice were injected intraperitoneally with 1unit/kg insulin (Actrapid Novo).
###end p 95
###begin p 96
###xml 15 19 <span type="species:ncbi:10090">mice</span>
When required, mice were injected with 200 mg/kg streptozotocin (Sigma).
###end p 96
###begin p 97
###xml 20 24 <span type="species:ncbi:10090">mice</span>
###xml 136 140 <span type="species:ncbi:10090">mice</span>
For urine analysis, mice were individually housed in metabolic cages with free access to water and a standard or glucose-rich diet. The mice were allowed to adapt to the cages for three days. Intake of food and water was then measured every 24 h and urine was collected throughout three consecutive days. Spontaneously excreted urine from each 24 h-period was collected for measurement of urinary creatinine and protein excretion.
###end p 97
###begin title 98
Indirect calorimetry
###end title 98
###begin p 99
###xml 78 82 78 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Even1">[53]</xref>
###xml 84 88 84 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Even2">[54]</xref>
###xml 293 297 293 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Even1">[53]</xref>
###xml 767 771 759 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Even1">[53]</xref>
###xml 773 777 765 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Even2">[54]</xref>
###xml 779 783 771 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Even3">[55]</xref>
These studies were conducted in an open-circuit, indirect calorimetric device [53], [54]. The apparatus was improved and developed within the framework of the AddenFi project, for the valorization and commercialization of laboratory setups, at INRA-AgroParisTech, INA-PG UMR 914 Research Unit [53]. The temperature in the metabolic cage was maintained at 32+/-1degreesC. Oxygen consumption and carbon dioxide production were recorded every 10 s using a computer-assisted data acquisition program written under Labview 7.1. A previously described stoichiometric formula was used to calculate oxidation of glucose and lipid. Protein oxidation was not taken into account. Resting and activity-related metabolic rates were calculated separately (Kalman filtering method) [53], [54], [55].
###end p 99
###begin p 100
###xml 4 8 <span type="species:ncbi:10090">mice</span>
The mice were placed in the metabolic cage at 9:00 a.m. with water, but no food, available. An oral glucose tolerance test (3.6 mg/g) was carried out at 2:00 p.m. and a calibrated test meal (1g of the standard diet) was given at 6:00 p.m. Respiratory exchanges and spontaneous activity were continuously recorded until 9:00 a.m. the following day.
###end p 100
###begin p 101
###xml 122 126 <span type="species:ncbi:10090">mice</span>
The basal metabolic rate was defined as the mean resting metabolic rate measured between 5:00 a.m. and 7:30 a.m. when the mice were in a post-absorptive state. The changes in metabolic rate, respiratory quotient, glucose and lipid oxidations induced by the OGTT and test meal were calculated relative to the stable pre-test values measured during the preceding hour.
###end p 101
###begin title 102
Total fat
###end title 102
###begin p 103
###xml 76 81 <span type="species:ncbi:10090">mouse</span>
###xml 113 117 <span type="species:ncbi:10090">Mice</span>
Total fat was determined by dual-energy X-ray absorptiometry (Lunar PIXImus mouse densitometer; GE LUNAR Corp.). Mice were fasted for 48h before the analysis and anesthetized with Avertin (0.02 ml/g body weight).
###end p 103
###begin title 104
Kidney echography
###end title 104
###begin p 105
###xml 32 39 32 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 213 217 213 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001288-Jouannot1">[56]</xref>
###xml 219 223 <span type="species:ncbi:10090">Mice</span>
Ultrasonic images were acquired in vivo using a clinical dermatological imaging system (Ultrasons Technologies, Tours, France) with custom modifications for dynamic data acquisition and high-frequency electronics [56]. Mice were anesthetized with 1.5% isoflurane.
###end p 105
###begin title 106
Statistical analyses
###end title 106
###begin p 107
###xml 54 55 52 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
Results are presented as means+/-S.E.M., and unpaired t test was used for data analysis unless indicated (i.e. ANOVA) (GraphPad Software).
###end p 107
###begin p 108
We thank Pr J. Chambaz and the members of UMR 505 INSERM-UPMC for constant support and fruitful discussions. We are most grateful to A. Blanchard and M. Pegorier-Lelievre for critical reading of the manuscript. We acknowledge the contribution of C. Lasne, N. Mokhatari-Comuce, M. Seau and V. Chauffeton for animal production and care. D. Chateau and J. Meurot are thanked for their contributions. We wish to thank M. Longchamps, E. Jouannot for DEXA and echography analysis and B. BrZant for giving access to morphometrical measurements.
###end p 108
###begin title 109
References
###end title 109
###begin article-title 110
Banting Lecture 1995. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm.
###end article-title 110
###begin article-title 111
Pancreatic beta-cell glucokinase: closing the gap between theoretical concepts and experimental realities.
###end article-title 111
###begin article-title 112
Glucose-regulated gene expression maintaining the glucose-responsive state of beta-cells.
###end article-title 112
###begin article-title 113
Mechanisms by which carbohydrates regulate expression of genes for glycolytic and lipogenic enzymes.
###end article-title 113
###begin article-title 114
Glucose regulation of gene transcription.
###end article-title 114
###begin article-title 115
Glucose as a regulator of eukaryotic gene transcription.
###end article-title 115
###begin article-title 116
###xml 28 52 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Two glucose transporters in Saccharomyces cerevisiae are glucose sensors that generate a signal for induction of gene expression.
###end article-title 116
###begin article-title 117
The eukaryotic plasma membrane as a nutrient-sensing device.
###end article-title 117
###begin article-title 118
Glucose activates mitogen-activated protein kinase (extracellular signal-regulated kinase) through proline-rich tyrosine kinase-2 and the Glut1 glucose transporter.
###end article-title 118
###begin article-title 119
###xml 70 74 <span type="species:ncbi:10090">mice</span>
Early diabetes and abnormal postnatal pancreatic islet development in mice lacking Glut-2.
###end article-title 119
###begin article-title 120
###xml 37 44 <span type="species:ncbi:9606">patient</span>
Fanconi-Bickel syndrome-the original patient and his natural history, historical steps leading to the primary defect, and a review of the literature.
###end article-title 120
###begin article-title 121
The large intracytoplasmic loop of the glucose transporter GLUT2 is involved in glucose signaling in hepatic cells.
###end article-title 121
###begin article-title 122
A glucose sensor hiding in a family of transporters.
###end article-title 122
###begin article-title 123
###xml 25 29 <span type="species:ncbi:10090">mice</span>
Evidence from glut2-null mice that glucose is a critical physiological regulator of feeding.
###end article-title 123
###begin article-title 124
Glucose uptake, utilization, and signaling in GLUT2-null islets.
###end article-title 124
###begin article-title 125
Distinct Classes of Central GLUT2-Dependent Sensors Control Counterregulation and Feeding.
###end article-title 125
###begin article-title 126
Acute hyperglycemia induces a global down-regulation of gene expression in adipose tissue and in skeletal muscle of healthy subjects.
###end article-title 126
###begin article-title 127
Deletion of the angiotensin type 2 receptor (AT2R) reduces adipose cell size and protects from diet-induced obesity and insulin resistance.
###end article-title 127
###begin article-title 128
The influence of dairy product consumption on body composition.
###end article-title 128
###begin article-title 129
###xml 69 72 <span type="species:ncbi:10116">rat</span>
The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas.
###end article-title 129
###begin article-title 130
ER stress and SREBP-1 activation are implicated in beta-cell glucolipotoxicity.
###end article-title 130
###begin article-title 131
###xml 69 73 <span type="species:ncbi:10116">rats</span>
The effects of fasting and feeding on preproinsulin messenger RNA in rats.
###end article-title 131
###begin article-title 132
Translational control of proinsulin synthesis by glucose.
###end article-title 132
###begin article-title 133
Glucose stimulates proinsulin biosynthesis by a dose-dependent recruitment of pancreatic beta cells.
###end article-title 133
###begin article-title 134
Glucose-regulated translational control of proinsulin biosynthesis with that of the proinsulin endopeptidases PC2 and PC3 in the insulin-producing MIN6 cell line.
###end article-title 134
###begin article-title 135
Glucose-induced translational control of proinsulin biosynthesis is proportional to preproinsulin mRNA levels in islet beta-cells but not regulated via a positive feedback of secreted insulin.
###end article-title 135
###begin article-title 136
Control of insulin gene expression in pancreatic beta-cells and in an insulin-producing cell line, RIN-5F cells. I. Effects of glucose and cyclic AMP on the transcription of insulin mRNA.
###end article-title 136
###begin article-title 137
Control of insulin gene expression in pancreatic beta-cells and in an insulin-producing cell line, RIN-5F cells. II. Regulation of insulin mRNA stability.
###end article-title 137
###begin article-title 138
###xml 25 28 <span type="species:ncbi:10116">rat</span>
Beta cell replication in rat pancreatic monolayer cultures. Effects of glucose, tolbutamide, glucocorticoid, growth hormone and glucagon.
###end article-title 138
###begin article-title 139
###xml 54 58 <span type="species:ncbi:10116">rats</span>
Compensatory growth of pancreatic beta-cells in adult rats after short-term glucose infusion.
###end article-title 139
###begin article-title 140
###xml 81 85 <span type="species:ncbi:10116">rats</span>
Pancreatic beta-cell regeneration after 48-h glucose infusion in mildly diabetic rats is not correlated with functional improvement.
###end article-title 140
###begin article-title 141
Glucose-dependent expansion of pancreatic beta-cells by the protein p8 in vitro and in vivo.
###end article-title 141
###begin article-title 142
###xml 29 32 <span type="species:ncbi:10116">rat</span>
Glucose promotes survival of rat pancreatic beta cells by activating synthesis of proteins which suppress a constitutive apoptotic program.
###end article-title 142
###begin article-title 143
###xml 132 136 <span type="species:ncbi:10116">rats</span>
Neogenesis vs. apoptosis a main components of pancreatic beta cell mass changes in glucose-infused normal and mildly diabetic adult rats.
###end article-title 143
###begin article-title 144
Gluco-lipotoxicity of the pancreatic beta cell.
###end article-title 144
###begin article-title 145
Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes.
###end article-title 145
###begin article-title 146
Glucotoxicity and beta-cell failure in type 2 diabetes mellitus.
###end article-title 146
###begin article-title 147
###xml 97 101 <span type="species:ncbi:10090">mice</span>
Reduced beta-cell mass and altered glucose sensing impair insulin-secretory function in betaIRKO mice.
###end article-title 147
###begin article-title 148
Beta-cell-specific ablation of the hepatocyte growth factor receptor results in reduced islet size, impaired insulin secretion, and glucose intolerance.
###end article-title 148
###begin article-title 149
Intrinsic regulators of pancreatic beta-cell proliferation.
###end article-title 149
###begin article-title 150
Drug-induced Fanconi's syndrome.
###end article-title 150
###begin article-title 151
###xml 38 45 <span type="species:ncbi:9606">patient</span>
Elements of diabetic nephropathy in a patient with GLUT 2 deficiency.
###end article-title 151
###begin article-title 152
Active sugar transport in health and disease.
###end article-title 152
###begin article-title 153
###xml 46 54 <span type="species:ncbi:9606">patients</span>
A low renal threshold for glucose in diabetic patients with a mutation in the hepatocyte nuclear factor-1alpha (HNF-1alpha) gene.
###end article-title 153
###begin article-title 154
###xml 49 54 <span type="species:ncbi:10090">mouse</span>
###xml 59 62 <span type="species:ncbi:9606">man</span>
HNF1alpha controls renal glucose reabsorption in mouse and man.
###end article-title 154
###begin article-title 155
Efficient selection for high-expression transfectants with a novel eukaryotic vector.
###end article-title 155
###begin article-title 156
Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression.
###end article-title 156
###begin article-title 157
Gene-selective modulation by a synthetic oxysterol ligand of the liver X receptor.
###end article-title 157
###begin article-title 158
Karyopherin alpha2: a control step of glucose-sensitive gene expression in hepatic cells.
###end article-title 158
###begin article-title 159
Differential activation of p44mapk (ERK1) by alpha-thrombin and thrombin-receptor peptide agonist.
###end article-title 159
###begin article-title 160
###xml 31 35 <span type="species:ncbi:10090">mice</span>
Dietary-fat-induced obesity in mice results in beta cell hyperplasia but not increased insulin release: evidence for specificity of impaired beta cell adaptation.
###end article-title 160
###begin article-title 161
###xml 114 118 <span type="species:ncbi:10090">mice</span>
Simple-sugar meals target GLUT2 at enterocyte apical membranes to improve sugar absorption: a study in GLUT2-null mice.
###end article-title 161
###begin article-title 162
Practical aspects of indirect calorimetry in laboratory animals.
###end article-title 162
###begin article-title 163
###xml 143 146 <span type="species:ncbi:10116">rat</span>
Utilisation of the method of Kalman filtering for performing the on-line computation of background metabolism in the free-moving, free-feeding rat.
###end article-title 163
###begin article-title 164
###xml 105 109 <span type="species:ncbi:10116">rats</span>
Energy restriction with protein restriction increases basal metabolism and meal-induced thermogenesis in rats.
###end article-title 164
###begin article-title 165
###xml 73 78 <span type="species:ncbi:10090">mouse</span>
High-frequency ultrasound detection and follow-up of Wilms' tumor in the mouse.
###end article-title 165
###begin p 166
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 166
###begin p 167
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: EBL and AL are grateful to CNRS, INSERM and UPMC for support. AL is recipient of ALFEDIAM Merck Lipha grant. MLG is an INSERM fellow and recipient of Benjamin Delessert and PNRD grants. ES is recipient of the French MRT and the Fondation pour la Recherche Medicale fellowships.
###end p 167

